OTC wart removers
This article was originally published in The Tan Sheet
Executive Summary
FDA finalizes proposed labeling amendment to the OTC wart remover final monograph in the Nov. 23 Federal Register. Intended for products containing 15% salicylic acid in a karaya gum, glycol plaster vehicle, the amendment mandates that label directions require use of an emery board to "smooth the wart's surface" and application of "a drop of warm water" before applying the medicated plaster. The proposed amendment was issued in January ("The Tan Sheet" Jan. 31, In Brief)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning